252 related articles for article (PubMed ID: 25298593)
1. Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.
Kumar N; Swaroop HS; Chakraborty A; Chandran S
Indian J Pharmacol; 2014; 46(5):560-1. PubMed ID: 25298593
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam-induced acute psychosis in a child.
Zaki SA; Gupta S
Indian J Pharmacol; 2014; 46(3):341-2. PubMed ID: 24987186
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam psychosis in children with epilepsy.
Kossoff EH; Bergey GK; Freeman JM; Vining EP
Epilepsia; 2001 Dec; 42(12):1611-3. PubMed ID: 11879376
[TBL] [Abstract][Full Text] [Related]
4. Acute psychosis associated with levetiracetam.
Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
[TBL] [Abstract][Full Text] [Related]
5. [Probable levetiracetam-induced psychosis].
Roig J; Carreño MM; Parellada E
Med Clin (Barc); 2007 Jul; 129(7):278. PubMed ID: 17683712
[No Abstract] [Full Text] [Related]
6. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Shukla G; Gupta A; Agarwal P; Poornima S
Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
[TBL] [Abstract][Full Text] [Related]
7. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
8. Re: Drug-induced psychosis with levetiracetam.
Mula M; Trimble MR
Can J Psychiatry; 2005 Dec; 50(14):948; author reply 948. PubMed ID: 16494265
[No Abstract] [Full Text] [Related]
9. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
Ben-Menachem E; Gilland E
Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
[TBL] [Abstract][Full Text] [Related]
10. The long term retention of levetiracetam in a large cohort of patients with epilepsy.
Depondt C; Yuen AW; Bell GS; Mitchell T; Koepp MJ; Duncan JS; Sander JW
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):101-3. PubMed ID: 16361605
[TBL] [Abstract][Full Text] [Related]
11. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
Mula M; Trimble MR; Sander JW
Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
14. Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria.
Dericioglu N; Saygi S
Metab Brain Dis; 2010 Jun; 25(2):207-9. PubMed ID: 20424903
[TBL] [Abstract][Full Text] [Related]
15. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
[TBL] [Abstract][Full Text] [Related]
16. Long-term continuation of levetiracetam in patients with refractory epilepsy.
Krakow K; Walker M; Otoul C; Sander JW
Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
[TBL] [Abstract][Full Text] [Related]
17. Probable levetiracetam-related serum alkaline phosphatase elevation.
Xiong N; Hou L; Lu N; Mohamed AA; Wang T; Huang Y
BMC Neurol; 2012 Sep; 12():97. PubMed ID: 22994584
[TBL] [Abstract][Full Text] [Related]
18. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam-induced psychosis in a pregnant woman with prior substance abuse.
Bui M; Baslet G; Weisholtz D; McElrath T
Harv Rev Psychiatry; 2014; 22(3):193-200. PubMed ID: 24802726
[No Abstract] [Full Text] [Related]
20. The safety of levetiracetam.
Sirsi D; Safdieh JE
Expert Opin Drug Saf; 2007 May; 6(3):241-50. PubMed ID: 17480174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
